Interesting (Times, £). The start of the piece:

“Thousands of men with incurable prostate cancer have been offered a “lifeline” as the NHS was given the go-ahead for a daily pill that slows the spread of the disease.

The National Institute for Health and Care Excellence (Nice) has reversed a decision to reject talazoparib, a drug made by Pfizer, which it said last summer was not cost-effective. It has now recommended the drug for about 2,400 men a year in England with advanced prostate cancer, and talazoparib will be available on the NHS from Friday.”

This follows the recent good news we reported about another life-extending prostate cancer drug (abiraterone) which will be offered to thousands in England, details here.

—————————-

If you’d like email notifications of our new blog pieces, please enter your email address in the box near the top of the right-hand column and click ‘Subscribe’.

We shall shortly be posting this piece on our X channel.

Our YouTube channel is here.